Boji Medical TechnologyLtd Past Earnings Performance
Past criteria checks 4/6
Boji Medical TechnologyLtd has been growing earnings at an average annual rate of 21.5%, while the Life Sciences industry saw earnings growing at 18.7% annually. Revenues have been growing at an average rate of 25.3% per year. Boji Medical TechnologyLtd's return on equity is 4.7%, and it has net margins of 5.9%.
Key information
21.5%
Earnings growth rate
18.0%
EPS growth rate
Life Sciences Industry Growth | 26.8% |
Revenue growth rate | 25.3% |
Return on equity | 4.7% |
Net Margin | 5.9% |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
We Don’t Think Boji Medical TechnologyLtd's (SZSE:300404) Earnings Should Make Shareholders Too Comfortable
Nov 02Boji Medical TechnologyLtd's (SZSE:300404) Profits Appear To Have Quality Issues
May 01Recent updates
We Don’t Think Boji Medical TechnologyLtd's (SZSE:300404) Earnings Should Make Shareholders Too Comfortable
Nov 02A Piece Of The Puzzle Missing From Boji Medical Technology Co.,Ltd.'s (SZSE:300404) 39% Share Price Climb
Oct 08Boji Medical TechnologyLtd's (SZSE:300404) Profits Appear To Have Quality Issues
May 01Further Upside For Boji Medical Technology Co.,Ltd. (SZSE:300404) Shares Could Introduce Price Risks After 35% Bounce
Mar 06Revenue & Expenses Breakdown
How Boji Medical TechnologyLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 753 | 45 | 145 | 63 |
30 Jun 24 | 665 | 37 | 137 | 58 |
31 Mar 24 | 620 | 29 | 130 | 56 |
31 Dec 23 | 556 | 24 | 124 | 55 |
30 Sep 23 | 504 | 29 | 117 | 51 |
30 Jun 23 | 481 | 30 | 112 | 48 |
31 Mar 23 | 453 | 27 | 108 | 45 |
01 Jan 23 | 424 | 28 | 104 | 44 |
30 Sep 22 | 388 | 27 | 98 | 37 |
30 Jun 22 | 379 | 40 | 95 | 34 |
31 Mar 22 | 343 | 44 | 87 | 30 |
01 Jan 22 | 324 | 39 | 80 | 28 |
30 Sep 21 | 298 | 31 | 74 | 30 |
30 Jun 21 | 271 | 19 | 71 | 28 |
31 Mar 21 | 295 | 30 | 67 | 28 |
31 Dec 20 | 260 | 17 | 67 | 26 |
30 Sep 20 | 259 | 20 | 64 | 23 |
30 Jun 20 | 241 | 16 | 62 | 22 |
31 Mar 20 | 209 | -1 | 66 | 21 |
31 Dec 19 | 224 | 7 | 67 | 18 |
30 Sep 19 | 201 | 7 | 67 | 16 |
30 Jun 19 | 189 | 5 | 61 | 15 |
31 Mar 19 | 177 | 4 | 57 | 13 |
31 Dec 18 | 172 | 7 | 54 | 13 |
30 Sep 18 | 155 | -16 | 60 | 13 |
30 Jun 18 | 153 | -19 | 54 | 16 |
31 Mar 18 | 152 | -16 | 52 | 13 |
31 Dec 17 | 131 | -24 | 51 | 10 |
30 Sep 17 | 121 | -3 | 45 | 7 |
30 Jun 17 | 103 | 4 | 50 | 0 |
31 Mar 17 | 74 | -1 | 47 | 0 |
31 Dec 16 | 72 | 2 | 45 | 0 |
30 Sep 16 | 81 | 11 | 40 | 0 |
30 Jun 16 | 88 | 12 | 40 | 0 |
31 Mar 16 | 111 | 22 | 38 | 0 |
31 Dec 15 | 127 | 26 | 37 | 0 |
30 Sep 15 | 150 | 39 | 30 | 0 |
30 Jun 15 | 153 | 39 | 29 | 0 |
31 Mar 15 | 148 | 39 | 28 | 0 |
31 Dec 14 | 144 | 38 | 27 | 0 |
31 Dec 13 | 136 | 35 | 22 | 0 |
Quality Earnings: 300404 has a large one-off gain of CN¥14.4M impacting its last 12 months of financial results to 30th September, 2024.
Growing Profit Margin: 300404's current net profit margins (5.9%) are higher than last year (5.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300404's earnings have grown significantly by 21.5% per year over the past 5 years.
Accelerating Growth: 300404's earnings growth over the past year (52.3%) exceeds its 5-year average (21.5% per year).
Earnings vs Industry: 300404 earnings growth over the past year (52.3%) exceeded the Life Sciences industry -14.4%.
Return on Equity
High ROE: 300404's Return on Equity (4.7%) is considered low.